نتایج جستجو برای: oncogene proteins

تعداد نتایج: 570601  

Journal: :journal of plant molecular breeding 2014
mehdi arefrad nadali babaian jelodar ghorbanali nematzadeh mohammadreza karimi seyedkamal kazemitabar

seed protein quality is an important topic in the production of soybean. the quality of soybean proteins is limited by anti-nutrient proteins and low levels of essential sulfur amino acids. in this study, protein content and solubility of six cultivars were evaluated and seed storage proteins were analyzed using sds-page and scanning densitometry. the results showed that seed storage protein ba...

Journal: :Science 1996
J Y Tsai L M Silver

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Federica Catalanotti David B Solit

The RAF inhibitor vemurafenib has unprecedented activity in BRAF-mutant melanomas, but resistance invariably develops. As Hsp90 is required for the stability of several of the oncoproteins that mediate RAF inhibitor resistance, inhibitors of this cellular chaperone may be effective in patients with intrinsic or acquired resistance to RAF inhibitors.

Journal: :Cancer research 1987
P E Kiefer G Bepler M Kubasch K Havemann

Amplification and expression of 16 protooncogenes were examined in 12 established small cell lung cancer (SCLC) cell lines. Seven of 12 cell lines showed a 20- to 35-fold amplification of the c-myc oncogene, 3 cell lines showed an 80- to 130-fold amplification of N-myc oncogene, and one cell line had a simultaneous amplification of the c-myb and N-myc oncogene. In this cell line both oncogenes ...

Safura Pakizehkar, Samaneh Hosseinzadeh,

Medullary thyroid cancer accounts for 5-10% of thyroid carcinomas. RET proto-oncogene mutations occur in all of the hereditary MTCs and about 66% of the sporadic MTCs. So, the detection of the RET mutations is necessary for rapid and proper diagnosis and treatment. This systematic review seeks to find a comprehensive list of RET gene mutations in the diagnosis of medullary thyroid cancer. The ...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2010

Journal: :Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1998
C E Nesbit L E Grove X Yin E V Prochownik

c-, N-, and L-myc are related nuclear oncoproteins that bind similar DNA sites and cooperate with activated ras oncogenes to transform primary fibroblasts. Although c-myc can also promote apoptosis in some cells after growth factor withdrawal or exposure to cytotoxic agents, roles for N- and L-myc in apoptosis remain undetermined. To address this, c-, N-, or L-myc were stably expressed in the i...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Howard C H Yim James C B Li John C H Pong Allan S Y Lau

c-Myc (Myc) is a well known transcription factor that regulates many essential cellular processes; however, its role in modulating immunity is not known. Here, we showed different species of mycobacteria can induce Myc expression via ERK1/2 and JNK activation. Unexpectedly, the induced Myc is localized in the cytoplasm but not in the nucleus. This induced Myc expression is associated with the i...

Journal: :Cold Spring Harbor perspectives in medicine 2014
Amy S Farrell Rosalie C Sears

The MYC oncoprotein is an essential transcription factor that regulates the expression of many genes involved in cell growth, proliferation, and metabolic pathways. Thus, it is important to keep MYC activity in check in normal cells in order to avoid unwanted oncogenic changes. Normal cells have adapted several ways to control MYC levels, and these mechanisms can be disrupted in cancer cells. O...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید